LockdownV1, Main, Exploration, bibRecord, 000445

Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.

Identifieur interne : 000445 ( Main/Exploration ); précédent : 000444; suivant : 000446

Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.

Auteurs : Estefanía Conde Blanco [Espagne] ; Isabel Manzanares [Espagne] ; María Centeno [Espagne] ; Mariam Khawaja [Espagne] ; Olga Betrán [Espagne] ; Antonio Donaire [Espagne] ; Mar Carre O [Espagne]

Source :

Acta neurologica Scandinavica [ 1600-0404 ] ; 2021.

RBID : pubmed:32990951

Descripteurs français

KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Anticonvulsivants (usage thérapeutique), Anxiété (complications), Contrôle des maladies transmissibles (MeSH), Crises épileptiques (épidémiologie), Dépression (complications), Enquêtes et questionnaires (MeSH), Espagne (épidémiologie), Femelle (MeSH), Humains (MeSH), Mâle (MeSH), Pandémies (MeSH), Patients en consultation externe (MeSH), Personnes handicapées (MeSH), Quarantaine (statistiques et données numériques), Troubles de la cognition (complications), Troubles de la veille et du sommeil (classification), Troubles de la veille et du sommeil (épidémiologie), Troubles mentaux (complications), Troubles mentaux (épidémiologie), Troubles moteurs (complications), Télémédecine (MeSH), Épilepsie (complications), Épilepsie (thérapie).
MESH :
- statistiques et données numériques : Quarantaine.
- thérapie : Épilepsie.
- usage thérapeutique : Anticonvulsivants, Anxiété, Dépression, Troubles de la cognition, Troubles de la veille et du sommeil, Troubles mentaux, Troubles moteurs, Épilepsie.
- épidémiologie : Crises épileptiques, Espagne, Troubles de la veille et du sommeil, Troubles mentaux.
- Adulte, Adulte d'âge moyen, Contrôle des maladies transmissibles, Enquêtes et questionnaires, Femelle, Humains, Mâle, Pandémies, Patients en consultation externe, Personnes handicapées, Télémédecine.
Wicri :
- geographic : Espagne.

English descriptors

KwdEn :
- Adult (MeSH), Anticonvulsants (therapeutic use), Anxiety (complications), COVID-19 (complications), COVID-19 (epidemiology), Cognition Disorders (complications), Communicable Disease Control (MeSH), Depression (complications), Disabled Persons (MeSH), Epilepsy (complications), Epilepsy (therapy), Female (MeSH), Humans (MeSH), Male (MeSH), Mental Disorders (complications), Mental Disorders (epidemiology), Middle Aged (MeSH), Motor Disorders (complications), Outpatients (MeSH), Pandemics (MeSH), Quarantine (statistics & numerical data), Seizures (epidemiology), Sleep Wake Disorders (classification), Sleep Wake Disorders (epidemiology), Spain (epidemiology), Surveys and Questionnaires (MeSH), Telemedicine (MeSH).
MESH :
- chemical , therapeutic use : Anticonvulsants.
- geographic , epidemiology : Spain.
- classification : Sleep Wake Disorders.
- complications : Anxiety, COVID-19, Cognition Disorders, Depression, Epilepsy, Mental Disorders, Motor Disorders.
- epidemiology : COVID-19, Mental Disorders, Seizures, Sleep Wake Disorders.
- statistics & numerical data : Quarantine.
- therapy : Epilepsy.
- Adult, Communicable Disease Control, Disabled Persons, Female, Humans, Male, Middle Aged, Outpatients, Pandemics, Surveys and Questionnaires, Telemedicine.

Abstract

BACKGROUND

Lockdown due to the SARS-CoV-2 pandemic became a challenge to maintain care for patients with epilepsy; we aimed to find out how the pandemic affected them.

METHODS

We sent an online 22-item questionnaire to patients from our outpatient clinic, a reference centre in Spain for drug-resistant epilepsy, inquiring about the effects of lockdown, from March to May 2020.

RESULTS

We sent the survey to 627 patients; 312 (58% women) sent a complete response and were included. Of all respondents, 57% took >2 antiseizure medications. One-third of respondents (29%) declared an associated cognitive or motor disability. A minority had confirmed infection with SARS-CoV-2 (1.92%). Seizure frequency remained like usual in 56% of patients, while 31.2% reported an increase. Less than 10% needed emergent assistance. Almost half reported anxiety or depression, and 25% increased behavioural disorders. Mood (F: 5.40; p: 0.002) and sleep disorders (F = 2.67; p: 0.05) were associated with increase in seizure frequency. Patients were able to contact their physicians when needed and were open to a future telematic approach to follow-up visits.

CONCLUSIONS

Seizure frequency and severity remained unchanged in most patients during the lockdown. Mood and sleep disorders were common and associated with seizure worsening. Patients were open to telematic care in the future.

DOI: 10.1111/ane.13354
PubMed: 32990951
PubMed Central: PMC7646661

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001499
to stream Main, to step Curation: 001499

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.</title>
<author><name sortKey="Conde Blanco, Estefania" sort="Conde Blanco, Estefania" uniqKey="Conde Blanco E" first="Estefanía" last="Conde Blanco">Estefanía Conde Blanco</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Manzanares, Isabel" sort="Manzanares, Isabel" uniqKey="Manzanares I" first="Isabel" last="Manzanares">Isabel Manzanares</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Centeno, Maria" sort="Centeno, Maria" uniqKey="Centeno M" first="María" last="Centeno">María Centeno</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Khawaja, Mariam" sort="Khawaja, Mariam" uniqKey="Khawaja M" first="Mariam" last="Khawaja">Mariam Khawaja</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Betran, Olga" sort="Betran, Olga" uniqKey="Betran O" first="Olga" last="Betrán">Olga Betrán</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Donaire, Antonio" sort="Donaire, Antonio" uniqKey="Donaire A" first="Antonio" last="Donaire">Antonio Donaire</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Carre O, Mar" sort="Carre O, Mar" uniqKey="Carre O M" first="Mar" last="Carre O">Mar Carre O</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:32990951</idno>
<idno type="pmid">32990951</idno>
<idno type="doi">10.1111/ane.13354</idno>
<idno type="pmc">PMC7646661</idno>
<idno type="wicri:Area/Main/Corpus">001499</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001499</idno>
<idno type="wicri:Area/Main/Curation">001499</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001499</idno>
<idno type="wicri:Area/Main/Exploration">001499</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.</title>
<author><name sortKey="Conde Blanco, Estefania" sort="Conde Blanco, Estefania" uniqKey="Conde Blanco E" first="Estefanía" last="Conde Blanco">Estefanía Conde Blanco</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Manzanares, Isabel" sort="Manzanares, Isabel" uniqKey="Manzanares I" first="Isabel" last="Manzanares">Isabel Manzanares</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Centeno, Maria" sort="Centeno, Maria" uniqKey="Centeno M" first="María" last="Centeno">María Centeno</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Khawaja, Mariam" sort="Khawaja, Mariam" uniqKey="Khawaja M" first="Mariam" last="Khawaja">Mariam Khawaja</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Betran, Olga" sort="Betran, Olga" uniqKey="Betran O" first="Olga" last="Betrán">Olga Betrán</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Donaire, Antonio" sort="Donaire, Antonio" uniqKey="Donaire A" first="Antonio" last="Donaire">Antonio Donaire</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Carre O, Mar" sort="Carre O, Mar" uniqKey="Carre O M" first="Mar" last="Carre O">Mar Carre O</name>
<affiliation wicri:level="3"><nlm:affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Acta neurologica Scandinavica</title>
<idno type="eISSN">1600-0404</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Anticonvulsants (therapeutic use)</term>
<term>Anxiety (complications)</term>
<term>COVID-19 (complications)</term>
<term>COVID-19 (epidemiology)</term>
<term>Cognition Disorders (complications)</term>
<term>Communicable Disease Control (MeSH)</term>
<term>Depression (complications)</term>
<term>Disabled Persons (MeSH)</term>
<term>Epilepsy (complications)</term>
<term>Epilepsy (therapy)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Mental Disorders (complications)</term>
<term>Mental Disorders (epidemiology)</term>
<term>Middle Aged (MeSH)</term>
<term>Motor Disorders (complications)</term>
<term>Outpatients (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Quarantine (statistics & numerical data)</term>
<term>Seizures (epidemiology)</term>
<term>Sleep Wake Disorders (classification)</term>
<term>Sleep Wake Disorders (epidemiology)</term>
<term>Spain (epidemiology)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Telemedicine (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Anticonvulsivants (usage thérapeutique)</term>
<term>Anxiété (complications)</term>
<term>Contrôle des maladies transmissibles (MeSH)</term>
<term>Crises épileptiques (épidémiologie)</term>
<term>Dépression (complications)</term>
<term>Enquêtes et questionnaires (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Patients en consultation externe (MeSH)</term>
<term>Personnes handicapées (MeSH)</term>
<term>Quarantaine (statistiques et données numériques)</term>
<term>Troubles de la cognition (complications)</term>
<term>Troubles de la veille et du sommeil (classification)</term>
<term>Troubles de la veille et du sommeil (épidémiologie)</term>
<term>Troubles mentaux (complications)</term>
<term>Troubles mentaux (épidémiologie)</term>
<term>Troubles moteurs (complications)</term>
<term>Télémédecine (MeSH)</term>
<term>Épilepsie (complications)</term>
<term>Épilepsie (thérapie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anticonvulsants</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Sleep Wake Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Anxiety</term>
<term>COVID-19</term>
<term>Cognition Disorders</term>
<term>Depression</term>
<term>Epilepsy</term>
<term>Mental Disorders</term>
<term>Motor Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>COVID-19</term>
<term>Mental Disorders</term>
<term>Seizures</term>
<term>Sleep Wake Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Quarantine</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Quarantaine</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Epilepsy</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Épilepsie</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticonvulsivants</term>
<term>Anxiété</term>
<term>Dépression</term>
<term>Troubles de la cognition</term>
<term>Troubles de la veille et du sommeil</term>
<term>Troubles mentaux</term>
<term>Troubles moteurs</term>
<term>Épilepsie</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Crises épileptiques</term>
<term>Espagne</term>
<term>Troubles de la veille et du sommeil</term>
<term>Troubles mentaux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Communicable Disease Control</term>
<term>Disabled Persons</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Outpatients</term>
<term>Pandemics</term>
<term>Surveys and Questionnaires</term>
<term>Telemedicine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Contrôle des maladies transmissibles</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Patients en consultation externe</term>
<term>Personnes handicapées</term>
<term>Télémédecine</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>Lockdown due to the SARS-CoV-2 pandemic became a challenge to maintain care for patients with epilepsy; we aimed to find out how the pandemic affected them.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>We sent an online 22-item questionnaire to patients from our outpatient clinic, a reference centre in Spain for drug-resistant epilepsy, inquiring about the effects of lockdown, from March to May 2020.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>We sent the survey to 627 patients; 312 (58% women) sent a complete response and were included. Of all respondents, 57% took >2 antiseizure medications. One-third of respondents (29%) declared an associated cognitive or motor disability. A minority had confirmed infection with SARS-CoV-2 (1.92%). Seizure frequency remained like usual in 56% of patients, while 31.2% reported an increase. Less than 10% needed emergent assistance. Almost half reported anxiety or depression, and 25% increased behavioural disorders. Mood (F: 5.40; p: 0.002) and sleep disorders (F = 2.67; p: 0.05) were associated with increase in seizure frequency. Patients were able to contact their physicians when needed and were open to a future telematic approach to follow-up visits.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>Seizure frequency and severity remained unchanged in most patients during the lockdown. Mood and sleep disorders were common and associated with seizure worsening. Patients were open to telematic care in the future.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32990951</PMID>
<DateCompleted><Year>2021</Year>
<Month>01</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0404</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>143</Volume>
<Issue>2</Issue>
<PubDate><Year>2021</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Acta neurologica Scandinavica</Title>
<ISOAbbreviation>Acta Neurol Scand</ISOAbbreviation>
</Journal>
<ArticleTitle>Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.</ArticleTitle>
<Pagination><MedlinePgn>206-209</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/ane.13354</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lockdown due to the SARS-CoV-2 pandemic became a challenge to maintain care for patients with epilepsy; we aimed to find out how the pandemic affected them.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We sent an online 22-item questionnaire to patients from our outpatient clinic, a reference centre in Spain for drug-resistant epilepsy, inquiring about the effects of lockdown, from March to May 2020.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We sent the survey to 627 patients; 312 (58% women) sent a complete response and were included. Of all respondents, 57% took >2 antiseizure medications. One-third of respondents (29%) declared an associated cognitive or motor disability. A minority had confirmed infection with SARS-CoV-2 (1.92%). Seizure frequency remained like usual in 56% of patients, while 31.2% reported an increase. Less than 10% needed emergent assistance. Almost half reported anxiety or depression, and 25% increased behavioural disorders. Mood (F: 5.40; p: 0.002) and sleep disorders (F = 2.67; p: 0.05) were associated with increase in seizure frequency. Patients were able to contact their physicians when needed and were open to a future telematic approach to follow-up visits.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Seizure frequency and severity remained unchanged in most patients during the lockdown. Mood and sleep disorders were common and associated with seizure worsening. Patients were open to telematic care in the future.</AbstractText>
<CopyrightInformation>© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Conde Blanco</LastName>
<ForeName>Estefanía</ForeName>
<Initials>E</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0001-7436-987X</Identifier>
<AffiliationInfo><Affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Manzanares</LastName>
<ForeName>Isabel</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Centeno</LastName>
<ForeName>María</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Khawaja</LastName>
<ForeName>Mariam</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Betrán</LastName>
<ForeName>Olga</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Donaire</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carreño</LastName>
<ForeName>Mar</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). EpiCARE Network, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>11</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Denmark</Country>
<MedlineTA>Acta Neurol Scand</MedlineTA>
<NlmUniqueID>0370336</NlmUniqueID>
<ISSNLinking>0001-6314</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006233" MajorTopicYN="N">Disabled Persons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068079" MajorTopicYN="N">Motor Disorders</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012893" MajorTopicYN="N">Sleep Wake Disorders</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">epilepsy</Keyword>
<Keyword MajorTopicYN="N">neuroepidemiology</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>07</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>09</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>09</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>9</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>12</Hour>
<Minute>39</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32990951</ArticleId>
<ArticleId IdType="doi">10.1111/ane.13354</ArticleId>
<ArticleId IdType="pmc">PMC7646661</ArticleId>
</ArticleIdList>
<ReferenceList><Title>REFERENCES</Title>
<Reference><Citation>Legido-Quigley H, Mateos-García JT, Campos VR, Gea-Sánchez M, Muntaner C, McKee M. The resilience of the Spanish health system against the COVID-19 pandemic. Lancet Public Heal. 2020;5(5):e251-e252.</Citation>
</Reference>
<Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA - J Am Med Assoc. 2020;323(13):1239-1242.</Citation>
</Reference>
<Reference><Citation>French JA, Brodie MJ, Caraballo R, et al. Keeping people with epilepsy safe during the Covid-19 pandemic. Neurology. 2020;94(23):1032-1037.</Citation>
</Reference>
<Reference><Citation>Hatcher-Martin JM, Adams JL, Anderson ER, et al. Telemedicine in neurology: telemedicine work group of the American academy of neurology update. Neurology. 2020;94(1):30-38.</Citation>
</Reference>
<Reference><Citation>Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179-2184.</Citation>
</Reference>
<Reference><Citation>General advice for persons with epilepsy Authors: ERNEpiCARE STEERING COMMITTEE. 2020. www.nhs.uk/conditions/coronavirus-covid-19. Accedidojunio 10, 2020.</Citation>
</Reference>
<Reference><Citation>Lai SL, Hsu MT, Chen SS. The impact of SARS on epilepsy: the experience of drug withdrawal in epileptic patients. Seizure. 2005;14(8):557-561.</Citation>
</Reference>
<Reference><Citation>Macêdo PJOM, de Oliveira PS, Foldvary-Schaefer N, da Gomes MM. Insomnia in people with epilepsy: a review of insomnia prevalence, risk factors and associations with epilepsy-related factors. Epilepsy Res. 2017;135:158-167.</Citation>
</Reference>
<Reference><Citation>Hao X, Zhou D, Li Z, et al. Severe psychological distress among epilepsy patients during the COVID-19 outbreak in southwest China. Epilepsia. 2020;61(6):1166-1173.</Citation>
</Reference>
<Reference><Citation>Bagot KL, Cadilhac DA, Bladin CF. Recommendation for an internationally agreed minimum data set for teleneurology. Nat Rev Neurol. 2018;14(11):687.</Citation>
</Reference>
<Reference><Citation>Ross L, Bena J, Bermel R, et al. Implementation and patient experience with outpatient subspecialty teleneurology visits at a single academic institution over four years. Neurology. 2019;92(15 Supplement 1). https://n.neurology.org/content/92/15_Supplement/Plen01.004. Accedido junio 5, 2020.</Citation>
</Reference>
<Reference><Citation>Assenza G, Lanzone J, Brigo F, et al. Epilepsy care in the time of COVID-19 pandemic in Italy: risk factors for seizure worsening. Front Neurol. 2020;11:737.</Citation>
</Reference>
<Reference><Citation>Conde Blanco E, Centeno M, Tio E, et al. Emergency implantation of telemedicine for epilepsy in Spain: results of a survey during SARS-CoV-2 pandemic. Epilepsy Behav. 2020;111:107211.</Citation>
</Reference>
<Reference><Citation>Miller WR, Von Gaudecker J, Tanner A, Buelow JM. Epilepsy self-management during a pandemic: experiences of people with epilepsy. Epilepsy Behav. 2020;111:107238.</Citation>
</Reference>
<Reference><Citation>Asadi-Pooya AA, Farazdaghi M, Bazrafshan M. Impacts of the COVID-19 pandemic on Iranian patients with epilepsy. Acta Neurol Scand. 2020;142(4):392-395.</Citation>
</Reference>
<Reference><Citation>Brooks DR, Avetisyan R, Jarrett KM. Validation of self-reported epilepsy for purposes of community surveillance. Epilepsy Behav. 2012;23(1):57-63. https://doi.org/10.1016/j.yebeh.2011.11.002</Citation>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
</region>
<settlement><li>Barcelone</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Catalogne"><name sortKey="Conde Blanco, Estefania" sort="Conde Blanco, Estefania" uniqKey="Conde Blanco E" first="Estefanía" last="Conde Blanco">Estefanía Conde Blanco</name>
</region>
<name sortKey="Betran, Olga" sort="Betran, Olga" uniqKey="Betran O" first="Olga" last="Betrán">Olga Betrán</name>
<name sortKey="Carre O, Mar" sort="Carre O, Mar" uniqKey="Carre O M" first="Mar" last="Carre O">Mar Carre O</name>
<name sortKey="Centeno, Maria" sort="Centeno, Maria" uniqKey="Centeno M" first="María" last="Centeno">María Centeno</name>
<name sortKey="Donaire, Antonio" sort="Donaire, Antonio" uniqKey="Donaire A" first="Antonio" last="Donaire">Antonio Donaire</name>
<name sortKey="Khawaja, Mariam" sort="Khawaja, Mariam" uniqKey="Khawaja M" first="Mariam" last="Khawaja">Mariam Khawaja</name>
<name sortKey="Manzanares, Isabel" sort="Manzanares, Isabel" uniqKey="Manzanares I" first="Isabel" last="Manzanares">Isabel Manzanares</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/LockdownV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000445 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000445 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    LockdownV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32990951
   |texte=   Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32990951" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LockdownV1

This area was generated with Dilib version V0.6.38.
Data generation: Sun Jan 31 08:28:27 2021. Site generation: Sun Jan 31 08:33:49 2021

	Serveur d'exploration sur le confinement (PubMed)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le confinement (PubMed)

Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.

Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki